Zee News Gefitinib is a targeted cancer therapy that blocks a tyrosine kinase enzyme to treat non-small cell lung cancers caused by mutations in the epidermal growth factor receptor. "This study raises the possibility that resistance to other tyrosine kinase ...
Newswise (press release) Cediranib is a drug that inhibits a class of proteins called vascular endothelial growth factor receptors which regulate blood vessel formation. The drug , developed by AstraZeneca, Wilmington, Del., has been tested in clinical trials against other ... and more »
Daily News & Analysis Gefitinib is a targeted cancer therapy that blocks a tyrosine kinase enzyme to treat non-small cell lung cancers caused by mutations in the epidermal growth factor receptor. “This study raises the possibility that resistance to other tyrosine kinase ... and more »
News-Medical.net Please can you give an introduction to the epidermal growth factor receptor (EGFR) and outline what was previously known about drug resistant brain tumors? In cancer, mutations in proteins that control cell growth are common, leading to unrestrained ...
Radio Australia DOUGLAS: There's a lot of factors contributing to the rebound, but the instability in the northern districts of the country, up in what's known as the Golden Triangle, it's fuelling some poverty and there's a lot of farmers that this is the only ... and more »
The News Journal Tiffany Maniscalco, 19, of the 1400 block of Cypress Ave., was charged with criminal impersonation, possession of a controlled except human growth hormone without a prescription with an aggravating factor , possession of drug paraphernalia, failure to ...
NEWS.com.au One of the other big factors has been the drug Tamoxifen which is prescribed to fight tumor growth in women who have breast cancer with tumors that are fuelled by estrogen, Professor Sitas sayid. Sinead Forbes says she owes her life to cancer research ... and more »
Post (subscription) Vijay Singh has admitted using deer antler spray, but says he was unaware the extract contained an insulin-like growth factor that is banned by the...
EurekAlert (press release) ... decision-making from drug discovery through drug development, announced that its Pharsight Consulting Services has developed a mathematical model of tumor growth inhibition, which when combined with baseline prognostic factors , predicts treatment ... and more »
Medical Xpress Gefitinib is a targeted cancer therapy that blocks a tyrosine kinase enzyme to treat non-small cell lung cancers caused by mutations in the epidermal growth factor receptor. "This study raises the possibility that resistance to other tyrosine kinase ...
